Ketorolac in Palatoplasty

Recruiting now · Phase 4 · Has a placebo group

Conditions studied: Cleft Lip and Palate

In brief

The purpose of this study is to see if the addition of IV Ketorolac to usual care multi-modal pain therapy compared to usual care will improve oral intake post-operatively

Key facts

Study ID

NCT04771156

Run by

The University of Texas Health Science Center, Houston

People needed

74

Starts

2021-09-17

Expected to finish

2027-04-01

Last updated by the study team

2026-02-19

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient with Cleft palate (Complete and incomplete), with or without cleft lip, unilateral or bilateral

You may not qualify if…

• Syndromic Cleft Palate patients
• Previous palatoplasty
• Major unrepaired cardiac malformation
• History of GI complications (GI Bleed, Gastric Ulceration)
• History of Renal disorder
• History of coagulopathy (As contraindication to NSAID use)
• Feeding tube dependency
• Patients whose parents refuse to consent to randomization

Where it is running

• The University of Texas Health Science Center at Houston — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.